Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis

Kristopher P. Croome, Amit K. Mathur, Shennen Mao, Bashar Aqel, Jacob Piatt, Peter Senada, Julie K. Heimbach, Adyr Moss, Charles B. Rosen, C. Burcin Taner

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background: Given the potentially additive risk from using donor livers that are both steatotic and from a donation after circulatory death (DCD) donor, there is a paucity of data on the outcome of DCD liver transplantation (LT) utilizing livers with macrosteatosis. Methods: All DCD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 1999 to 2019 were included (N = 714). Recipients of DCD LT were divided into 3 groups: those with moderate macrosteatosis (30%-60%), mild macrosteatosis (5%-30%), and no steatosis (<5%). Results: Patients with moderate macrosteatosis had a higher rate of postreperfusion syndrome (PRS; 53.9% vs 26.2%; P =.002), postreperfusion cardiac arrest (7.7% vs 0.3%; P <.001), primary nonfunction (PNF; 7.7% vs 1.0%; P =.003), early allograft dysfunction (EAD; 70.8% vs 45.6% and 8.3%; P =.02), and acute kidney injury (AKI; 39.1% vs 19.4%; P =.02) than patients with no steatosis. No difference in any of the perioperative complications was seen between the mild macrosteatosis and the no steatosis groups except for the rate of EAD (56.8% vs 45.6%; P =.04). No difference in ischemic cholangiopathy (IC), vascular thrombosis/stenosis or graft, and patient survival was seen between the 3 groups. Conclusion: DCD donors with mild macrosteatosis < 30% can be utilized with no increase in perioperative complications and similar patient and graft survival compared to DCD donors with no steatosis. When utilizing DCD donors with moderate macrosteatosis higher rates of PRS, PNF, postreperfusion cardiac arrest, EAD, and AKI should be anticipated.

Original languageEnglish (US)
Pages (from-to)2449-2456
Number of pages8
JournalAmerican Journal of Transplantation
Issue number9
StatePublished - Sep 1 2020


  • clinical research/practice
  • donors and donation: donation after circulatory death (DCD)
  • donors and donation: extended criteria
  • liver transplantation/hepatology
  • organ procurement and allocation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)


Dive into the research topics of 'Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis'. Together they form a unique fingerprint.

Cite this